Maravai LifeSciences Announces March 2021 Investor Conference Schedule
Maravai LifeSciences, Inc. (NASDAQ: MRVI) announced its participation in two virtual investor conferences.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Maravai LifeSciences, Inc. (NASDAQ: MRVI) announced its participation in two virtual investor conferences. CEO Carl Hull will present at the Cowen Health Care Conference on March 3, 2021, at 10:20 a.m. PT. He will also engage in a fireside chat at the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum on March 23, 2021, at 8:30 a.m. PT. Webcasts of these events will be accessible via Maravai's investor relations website, with archived versions available shortly after the events.
Details
News Market Reaction – MRVI
The recorded move for MRVI in the trading session of this news was +12.15%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN DIEGO, March 01, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in two upcoming virtual investor conferences.
On March 3, 2021, Carl Hull, Chief Executive Officer, is scheduled to present at the Cowen Health Care Conference at 10:20 a.m. PT.
On March 23, 2021, Hull will participate in a fireside chat at the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum at 8:30 a.m. PT.
A live webcast of the presentations will be available to all interested parties on the Maravai Lifesciences investor relations website at http://investors.maravai.com. An archived version of the webcast will be available a few hours following the completion of each event on the Maravai investor relations website.
About Maravai
Maravai is a leading life sciences company providing critical products to enable the development of drug therapies, diagnostics, novel vaccines and support research on human diseases. Maravai’s companies are leaders in providing products and services in the fields of nucleic acid synthesis, bioprocess impurity detection and analysis, and protein labeling and detection to many of the world's leading biopharmaceutical, vaccine, diagnostics, and cell and gene therapy companies.
For more information about Maravai LifeSciences, visit www.maravai.com.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.